James Kalabus
Overview
Explore the profile of James Kalabus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Subbiah V, Chawla S, Conley A, Wilky B, Tolcher A, Lakhani N, et al.
Clin Cancer Res
. 2023 Jun;
29(16):2988-3003.
PMID: 37265425
Purpose: Patients with unresectable/metastatic chondrosarcoma have poor prognoses; conventional chondrosarcoma is associated with a median progression-free survival (PFS) of <4 months after first-line chemotherapy. No standard targeted therapies are available....
2.
Horibe K, Morris J, Tuglus C, Dos Santos C, Kalabus J, Anderson A, et al.
Int J Hematol
. 2020 Jun;
112(2):223-233.
PMID: 32564243
Novel therapies are needed for children with relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (ALL). Blinatumomab is a bispecific T-cell engager immunotherapy that simultaneously binds to CD3-positive cytotoxic T cells...
3.
Kiyoi H, Morris J, Oh I, Maeda Y, Minami H, Miyamoto T, et al.
Cancer Sci
. 2020 Jan;
111(4):1314-1323.
PMID: 31971321
Adult patients with relapsed/refractory (R/R) B-precursor acute lymphoblastic leukemia (ALL) have a poor prognosis. Blinatumomab is a bispecific T-cell engager (BiTE) immuno-oncology therapy with dual specificity for CD19 and CD3...
4.
Topp M, Duell J, Zugmaier G, Attal M, Moreau P, Langer C, et al.
J Clin Oncol
. 2020 Jan;
38(8):775-783.
PMID: 31895611
Purpose: The anti-B-cell maturation antigen BiTE molecule AMG 420 was assessed in patients with relapsed/refractory multiple myeloma. Patients And Methods: In this first-in-human study, up to 10 cycles of AMG...
5.
Brian W, Tremaine L, Arefayene M, de Kanter R, Evers R, Guo Y, et al.
Pharmacogenomics
. 2016 Apr;
17(6):615-31.
PMID: 27045656
Genetic variants of drug metabolism enzymes and transporters can result in high pharmacokinetic and pharmacodynamic variability, unwanted characteristics of efficacious and safe drugs. Ideally, the contributions of these enzymes and...